The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21(Cip1)-mediated inhibition of cdk2

Genes and Development

Volumn 11, Issue 16, 1997, Pages 2101-2111

  Jones, D Leanne ^a   Alani, Rhoda M ^a,b   Münger, Karl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell division cycle; Cellular differentiation; Cyclin dependent kinase inhibitor; Human papillomavirus

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; DNA; GLUTATHIONE TRANSFERASE; ONCOPROTEIN; PROTEIN P21; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0030756473     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.16.2101     Document Type: Article

References (67)

1. Arany, Z., D. Newsome, E. Oldread, D.M. Livingston, and R. Eckner. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374: 81-84.
2. Baden, H.P. and J.C. Kvedar. 1993. Epithelial cornified envelope precursors are in the hair follicle and nail. J. Invest. Dermatol. 101: 72S-74S.
3. Bannister, A.J. and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643.
4. Billon N., L.A. van Grunsven, and B.B. Rudkin. 1996. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13: 2047-2054.
5. Blanton, R.A., M.D. Coltrera, A.M. Gown, C.L. Halbert, and J.K. McDougall. 1992. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Diff. 3: 791-802.
6. Bosch, F.X., M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, K.V. Shah, E. Alihonou, S. Bayo, H.C. Mokhtar, S. Chicareon, A. Daudt, E. Delosrios, P. Ghadirian, J.N. Kitinya, M. Koulibaly, C. Ngelangel, L.M.P. Tintore, J.L. Riosdalenz, A. Sarjadi-Schneider, L. Tafur, A.R. Teyssie, P.A. Rolon, M. Torroella, A.V. Tapia, H.R. Wabinga, W. Zatonski, B. Sylla, P. Vizcaino, D. Magnin, J. Kaldor, C. Greer, and C. Wheeler. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J. Nat. Cancer Inst. 87: 796-802.
7. Boyer, S.N., D.E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquiun-proteasome pathway. Cancer Res. 56: 4620-4624.
8. Cheng, S., D.C. Schmidt-Grimminger, T. Murant, T.R. Broker, and L.T. Chow. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes & Dev. 9: 2335-2349.
9. Ciccolini F., G. Dipasquale, F. Carlotti, L. Crawford, and M. Tommasino. 1994. Functional studies ot E7 proteins from different HPV types. Oncogene 9: 2633-2638.
10. Datto, M.B., P.P. Hu, T.F. Kowalik, J. Yingling, and X.F. Wang. 1997. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17: 2030-2037.
11. Davies, R., R. Hicks, T. Crook, J. Morris, und K. Vousden. 1993. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67: 2521-2528.
12. Demers, G.W., S.A. Foster, C.L. Halbert, and D.A. Galloway. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. 91: 4382-4386.
13. Demers, G.W., E. Espling, J.B. Harry, B.G. Etscheid, and D.A. Galloway. 1996. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J. Virol. 70: 6862-6869.
14. Dyson, N., P. Guida, K. Münger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66: 6893-6902.
15. Eckner, R. 1996. p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377: 685-688.
16. Eckner, R., M.E. Ewen, D. Newsome, M. Gerdes, J.A. DeCaprio, J.B. Lawrence, and D.M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes & Dev. 8: 869-884.
17. Eckner, R., J.W. Ludlow, N.L. Lill, E. Oldread, Z. Arany, N. Modjtahedi, I.A. Decaprio, D.M. Livingston, and J.A. Morgan. 1996. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16: 3454-3464.
18. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
19. Foster, S.A., G.W. Demers, B.G. Etscheid, and D.A. Galloway. 1994. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68: 5698-5705.
20. Fuchs, E. 1993. Epidermal differentiation and keratin gene expression. J. Cell Sci. (Suppl.) 17: 197-208.
21. Gu, Z.M., D. Pim, S. Labrecque, L. Banks, and G. Matlashewski. 1994. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6. Oncogene 9: 629-633.
22. Guo, K., J.A. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15: 3823-3829.
23. Halbert, C.L., W. Demers, and D.A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65: 473-478.
24. _. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activty in human epithelial cells. J. Virol. 66: 2125-2134.
25. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
26. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
27. Hickman, E.S., S.M. Picksley, and K.H. Vousden. 1994. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene 9: 2177-2181.
28. Hickman, E.S., S. Bates, and K.H. Vousden. 1997. Perturbation of the p53 response by human papillomavirus type 16 E7. J. Virol. 71: 3710-3718.
29. Howley, P.M. 1996. Papillomavirinae: The viruses and their replication. In Fundamental virology (ed. B.N. Fields, D.M. Knipe and P.M. Howleyl, pp. 947-978. Lippincott-Raven Publishers, Philadelphia, PA.
30. Jiang, H.P., J. Lin, Z.Z. Su, F.R. Collart, E. Huberman, and P.B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406.
31. Jones, D.E. and K. Münger. 1997. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71: 2905-2912.
32. Kessis, T.D., R.J. Slebos, W.G. Nelson, M.B. Kastan, B.S. Plunkett, S.M. Han, A.T. Lorincz, E. Hedrick, and K.R. Cho. 1993. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. 90: 3988-3992.
33. Laiho, M., J.A. DeCaprio, J.W. Ludlow, D.M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185.
34. Low, K.G., L.F. Dorner, D.B. Fernando, J. Grossman, K.T. Jeang, and M.J. Comb. 1997. Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p 16INK4a. J. Virol. 71: 1956-1962.
35. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
36. Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380: 262-265.
37. Matsumura, I., J. Ishikawa, K. Nakajima, K. Oritani, Y. Tomiyama, J. Miyagawa, T. Kato, H. Miyazaki, Y. Matsuzawa, and Y. Kanakura. 1997. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17: 2933-2943.
38. McIntyre, M.C., M.N. Ruesch, and L.A. Laimins. 1996. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 215: 73-82.
39. Miller, A.D. and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-982.
40. Missero, C., E. Calautti, R. Eckner, J. Chin, E.H. Tsai, D.M. Livingston, and G.P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. 92: 5451-5455.
41. Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G.P. Dotto. 1996. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes & Dev. 10: 3065-3075.
42. Münger, K., B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, and P.M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8: 4099-4105.
43. Ogryzko, V.V., R.L. Schiltz, V. Russanova, B.H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
44. Parker, S.B., G. Eichele, P.M. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elledge. 1995. P53-independent expression of p21(Cip)1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
45. Phelps, W.C., K. Münger, C.L. Yee, J.A. Barnes, and P.M. Howley. 1992. Structure-function analysis of the human papillo-mavirus E7 oncoprotein. J. Virol. 66: 2418-2427.
46. Pietenpol, J.A., R.W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R.M. Lyons, M.R. Pittelkow, K. Münger, P.M. Howley, and H.L. Moses. 1990. TGFb1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785.
47. Pines, J. 1993. Cyclins and cyclin-dependent kinases - Take your partners. Trends Biochem. Sci. 18: 195-197.
48. Pittelkow, M.R., J.J. Wille, and R.E. Scott. 1986. Two functionally distinct classes of growth arrest states in human prokeratinocytes that regulate clonogenic potential. J. Invest. Dermatol. 86: 410-417.
49. Polyak, K. 1996. Negative regulation of cell growth by TGF beta. Biochim. Biophys. Acta 1242: 185-199.
50. Poumay, K. and M. Pittelkow. 1995. Cell density and culture factors regulate keratmocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J. Invest. Dermatol. 104: 271-276.
51. Rheinwald, J.G. and M.A. Beckett. 1981. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 41: 1657-1663.
52. Scheffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
53. Schlegel, R., W.C. Phelps, Y.-L. Zhang, and M. Barbosa. 1988. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7: 3181-3187.
54. Slebos, R.J.C., M.H. Lee, B.S. Plunkett, T.D. Kessis, B.O. Williams, T. Jacks, L. Hedrick, M.B. Kastan, and K.R. Cho. 1994. p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein Proc. Natl. Acad. Sci. 91: 5320-5324.
55. Steinman, R.A., B. Hoffman, A. Iro, C. Guillouf, D.A. Liebermann, and M.E. Elhouseini. 1994. Induction of p21 [WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396.
56. Suzuki, T., S. Kitao, H. Matsushime, and M. Yoshida. 1996. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15: 1607-1614.
57. Tommasino, M., J.P. Adamczewski, F. Carlotti, C.F. Barth, R. Manetti, M. Contorni, F. Cavalieri, T. Hunt, and L. Crawford. 1993. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8: 195-202.
58. Vousden, K.H. 1995. Regulation of the cell cycle by viral oncoproteins. Sem. Cancer Biol. 6: 109-116
59. Vousden, K.H., B. Vojtesek, C. Fisher, and D. Lane. 1993. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53. Oncogene 8: 1697-1702.
60. Werness, B.A., A.J. Levine, and P.M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
61. Woodworth, C.D., S. Cheng, S. Simpson, L. Harnacher, L.T. Chow, T.R. Broker, and J.A. DiPaolo. 1992. Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 7: 619-626.
62. Wu, E.W., K.E. Clemens, D.V. Heck, and K. Münger. 1993. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J. Virol. 67: 2402-2407.
63. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
64. Yang, X.J., V.V. Ogryzko, J. Nishikawa, B.H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319-324.
65. Zerfass-Thome, K., W. Zwerschke, B. Mannhardt, R. Tindle, J.W. Botz, and P. Jansen-Durr. 1996. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13: 2323-2330.
66. Zhu, L., E. Harlow, and B.D. Dynlacht. 1995. p 107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes & Dev. 9: 1740-1752.
67. zur Hausen, H. 1996. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288: F55-F78.